Kardigan, Inc. (KARD) vs Tyra Biosciences, Inc. (TYRA)
A side-by-side comparison of Kardigan, Inc. and Tyra Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KARD
Kardigan, Inc.
$14.31HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
TYRA
Tyra Biosciences, Inc.
$20.18HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — KARD vs TYRA
growth of $100 · dividends reinvested · last 1yKARD -30.7% (-30.7%/yr)TYRA -26.1% (-26.1%/yr)TYRA compounded faster over this window
KARD TYRA
KARD vs TYRA: by the numbers
- •KARD is the larger company ($1.28B vs $1.20B market cap).
Metrics side by side
Valuation
| Metric | KARD | TYRA |
|---|---|---|
| P/B ratio | 2.08 | 3.40 |
Profitability
| Metric | KARD | TYRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -42.01% |
| ROIC | -57.11% | -44.73% |
Growth (annualized)
| Metric | KARD | TYRA |
|---|---|---|
| Total return CAGR (5Y) | N/A | 9.23% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.